review of glp 1 Cardiovascular Effects and Tolerability GLP-1 Receptor Agonists: A Systematic and Meta-Analysis of 99,599 Patients Scientists rethink GLP-1 delivery to
Description
Discovery of a novel series of orally bioavailable and CNS penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) non-competitive antagonists based on a 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione core
Insert the needle into the retatrutide vial and angle it so the tip touches the glass wall
Published 2023 Feb 3
It is added because it addresses two specific and significant clinical problems that arise from GLP-1 receptor agonist therapy: nausea at treatment initiation and progressive B12 depletion over the course of long-term use
